C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2011
11/01/2011	US8048415 Compositions and methods for promoting or inhibiting angiogenesis
11/01/2011	US8048412 Enzyme with microbial lysis activity from Trichoderma reesei
11/01/2011	CA2493722C Method for recovering peptides/amino acids and oil/fat from one or more protein-containing raw materials, products produced by the method, and use of the products
11/01/2011	CA2447602C Anti-trail-r antibodies
11/01/2011	CA2396718C Pre-transplant accomodated organs resistant to anti-donor immunity
11/01/2011	CA2379100C Methods for reducing the formation of byproducts in the production of recombinant polypeptides
11/01/2011	CA2376299C Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
11/01/2011	CA2279196C Antigenic inducer and substances prepared therefrom
11/01/2011	CA2235443C Novel insulin derivatives having a rapid onset of action
11/01/2011	CA2221192C Embedded expression of heterologous proteins
11/01/2011	CA2176942C Bmp-12, bmp-13 and tendon-inducing compositions thereof
11/01/2011	CA2105903C Methods and compositions for the detection of soluble .beta.-amyloid peptide
10/2011
10/27/2011	WO2011131491A1 Method of producing soluble recombinant protein
10/27/2011	WO2011131231A1 System for the in vitro transcription and translation of membrane proteins
10/27/2011	WO2011112566A3 Basigin binding proteins
10/27/2011	WO2011069227A8 Anti-microbial agent from paenibacillus sp. and methods and uses thereof
10/27/2011	WO2011049418A9 Novel ginsenoside glycosidase derived from the genus terrabacter, and use thereof
10/27/2011	US20110265226 Improved production of proteins with downstream box fusions in plastids and in bacteria
10/27/2011	US20110265195 Unique associated kaposi's sarcoma virus sequences and uses thereof
10/27/2011	US20110263835 Recombinant nell protein production
10/27/2011	US20110263828 Methods for modifying human antibodies by glycan engineering
10/27/2011	US20110263825 Anti-cd20 monoclonal antibodies
10/27/2011	US20110263505 Whey Protein Hydrolysate Containing Tryptophan Peptide Consisting of Alpha Lactalbumin and the Use Thereof
10/27/2011	US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011	US20110263501 Growth Hormone Conjugate with Increased Stability
10/27/2011	US20110263484 Single chain fc type iii interferons and methods of using same
10/27/2011	US20110263047 Peptide tag and uses thereof
10/27/2011	US20110262969 Method for producing optically active, cyclic depsipeptides comprising lactic acid and phenyl lactic and having 24 ring atoms, using fungus strains of rosellinia type, and further species of xylariaceae
10/27/2011	US20110262968 Antibodies that bind to psca proteins for diagnosis of cancer
10/27/2011	US20110262967 Use of hsa-producing cells
10/27/2011	US20110262966 Dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants
10/27/2011	US20110262965 Cell culture medium comprising small peptides
10/27/2011	US20110262964 Reagentless fluorescent biosensors comprising a designed ankyrin repeat protein module, rational design methods to create reagentless fluorescent biosensors and methods of their use
10/27/2011	US20110262963 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
10/27/2011	US20110262962 Method for producing peptides
10/27/2011	US20110262953 Phosphate Limited Inducible Promoter and A Bacillus Expression System
10/27/2011	US20110262946 Monitoring a dynamic system by liquid chromatography-mass spectrometry
10/27/2011	US20110262944 Construction and crystallization of expression system for rna polymerase pb1-pb2 protein derived from influenza virus
10/27/2011	US20110262706 Template for bacterial cellulose implant processed within bioreactor
10/27/2011	US20110262474 Chimeric HIV Antigens
10/27/2011	US20110262452 Anti-hepsin antibodies and methods using same
10/27/2011	US20110262445 Anti-il-12/il-23 antibodies
10/27/2011	US20110262439 Bispecific single chain antibodies with specificity for high molecular weight target antigens
10/27/2011	US20110262438 Biological materials related to cxcr7
10/27/2011	US20110262430 Novel antibodies
10/27/2011	US20110262429 Human timp-1 antibodies
10/27/2011	US20110262408 Furin-knockdown and gm-csf-augmented (fang) cancer vaccine
10/27/2011	US20110262400 Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
10/27/2011	US20110262392 Medium derived from stem cells as a pharmaceutical composition
10/27/2011	US20110262353 Muteins of hngal and related proteins with affinity for a given target
10/26/2011	EP2380979A1 Protein substance having triple helix structure and manufacturing method therefor
10/26/2011	EP2380913A1 Novel anti-IGF-IR antibodies and uses thereof
10/26/2011	EP2380911A1 Antigen binding molecules with increased Fc receptor binding affinity and effector function
10/26/2011	EP2380910A1 Antigen binding molecules with increased Fc receptor binding affinity and effector function
10/26/2011	EP2380581A1 Muscle-building agent
10/26/2011	EP2380435A2 Feline-derived protein and method for production thereof
10/26/2011	EP2379716A1 Polypeptides having alpha-mannosidase activity and polynucleotides encoding same
10/26/2011	EP2379578A1 Dual charging system for selectively introducing non-native amino acids into proteins using an in vitro synthesis method
10/26/2011	EP2379098A1 Compositions and methods to prevent cancer with cupredoxins
10/26/2011	EP2150561B1 Demannosylated recombinant factor VIII for the treatment of patients with haemophilia A
10/26/2011	EP1911839B1 Peptide-forming enzyme gene, peptide-forming enzyme, and dipeptide producing method
10/26/2011	EP1692158B1 Vegf binding and supported peptides for treating skin diseases
10/26/2011	EP1668135B1 A non-denaturing process to purify recombinant proteins from plants
10/26/2011	EP1575509B1 Epha2 agonistic monoclonal antibodies and methods of use thereof
10/26/2011	EP1469310B1 Diagnostic for scleroderma
10/26/2011	EP1409748B1 Recombinant Adenoviruses comprising simian adenovirus proteins and uses thereof.
10/26/2011	EP0958046B1 Cell separation composition, kit and method
10/26/2011	EP0787191B2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
10/26/2011	CN1922313B Acid alpha-glucosidase and fragments thereof
10/26/2011	CN1678624B Benzoate- and anthranilate-inducible promoters
10/26/2011	CN102227445A Antibody capable of binding to envelope protein 2 of hepatitis c virus, and method for identifying genotype of hepatitis c virus using same
10/26/2011	CN102226182A Sequence and application of promoter of human autophagic gene Beclin 1
10/26/2011	CN101717807B Process for preparing chicken liver hydrolyzed protein with proteases
10/26/2011	CN101664543B Hemokinin-iron oral liquid
10/26/2011	CN101228271B Method for bacillus coli to high effectively excrine representing lysostaphin
10/26/2011	CN101003802B Method for preparing maturation peptide of morphogenesis protein - 2 of human bones
10/25/2011	US8044266 AXMI-008, a delta-endotoxin gene and methods for its use
10/25/2011	US8044261 Glyphosate-N-acetyltransferase (GAT) genes
10/25/2011	US8044192 Trichoderma promoter
10/25/2011	US8044191 Using expression vector comprising nucleotide sequences coding elongation factor regulatory sequences as high efficiency gene transfer tool
10/25/2011	US8044181 Antibodies to the PcrV antigen of Pseudomonas aeruginosa
10/25/2011	US8044180 FcγRIIB specific antibodies and methods of use thereof
10/25/2011	US8044178 Anti-5T4 antibodies and uses thereof
10/25/2011	US8044174 Thrombopoietic compounds
10/25/2011	US8044025 Urocortin proteins and uses thereof
10/25/2011	US8043850 Fluorescent protein and gene encoding the same
10/25/2011	US8043842 Bacteria with reduced genome
10/25/2011	US8043839 Xylanases, nucleic acids encoding them and methods for making and using them
10/25/2011	US8043837 Aldolases, nucleic acids encoding them and methods for making and using them
10/25/2011	US8043833 Expression of soluble therapeutic proteins
10/25/2011	US8043832 Method for determination of inflammatory bowel disease
10/25/2011	US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011	US8043830 Biotin-ligase system for secretion of biotinylated protein
10/25/2011	US8043829 DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression
10/25/2011	US8043827 Single molecule-format real-time bioluminescence imaging probe
10/25/2011	US8043638 Mutant ILV5 gene and use thereof
10/25/2011	CA2544462C Immortalized avian cell lines for virus production
10/25/2011	CA2437866C Novel clock gene bmal2
10/25/2011	CA2409007C Novel laccase enzyme and the gene encoding the enzyme
10/25/2011	CA2399865C Novel scavenger receptor

1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 1125